We therefore had the opportunity to analyse retrospective data available for the year 2010 from three distinct sources: blood glucose concentration measurements, both from the bedside and the laboratory; medication records for treatments (glucose, glucagon) commonly given to reverse hypoglycemia; and diagnostic codes for individual patients. This evidence concerns the gene GCG and Hypoglycemia.